Group 1 - The Shanghai Composite Index rose by 0.96% to close at 3617.6 points, while the Hang Seng Index increased by 0.68% to 24902.53 points [1] - Fudan Zhangjiang's A/H premium reached 177.33%, ranking fourth among A/H shares [1] - Fudan Zhangjiang's A-shares closed at 10.92 yuan, down 0.27%, and H-shares closed at 4.3 HKD, up 1.65% [1] Group 2 - Fudan Zhangjiang Biopharmaceutical Co., Ltd. was established in November 1996 in the Zhangjiang Hi-Tech Park, Shanghai, with notable shareholders including Shanghai Pharmaceuticals Holding Co., Ltd. [1] - The company focuses on innovative research, development, production, and sales in the biopharmaceutical sector, aiming to become a knowledge-based innovation enterprise [1] - Fudan Zhangjiang has developed competitive advantages in areas such as gene technology drugs, photodynamic technology drugs, nanotechnology drugs, and oral solid dosage technology drugs, with new products expected to be launched in the market [1]

作者：行情君 中远海发AH溢价达128.51%，位居AH股溢价率第15位。当日收盘，中远海发A股报2.49元，涨幅 0.4%，H股报1.19港元，上涨2.59%。 *注：AH股是指同时在A股和港股上市的公司，溢价（A/H）越大，说明H股相比A股越便宜。 8月5日，上证指数涨0.96%，收报3617.6点，恒生指数涨0.68%，收报24902.53点。 本文源自：金融界 资料显示，中远海运发展股份有限公司(「公司」)是中国远洋海运集团有限公司(「中远海运集团」)所 属专门从事航运物流产融运营的公司,是中远海运集团旗下核心产业之一。公司成立于1997年,总部设在 上海,是一家在香港、上海两地上市的公司。公司致力于围绕航运物流产业主线,以集装箱制造、集装箱 租赁及航运租赁业务为核心,以投资管理为支撑,实现产融投一体化发展。公司集装箱制造业务从事国际 标准干货箱、冷藏箱及特种箱的研究开发和生产销售,设计年产能超过140万TEU,位居世界第二,客户涵 盖全球知名班轮公司和各大租箱公司。公司深化集装箱租造协同,以科技创新、绿色低碳转型为抓手提 升核心竞争力,打造世界一流物流装备科技企业。 ...

作者：行情君 8月5日，上证指数涨0.96%，收报3617.6点，恒生指数涨0.68%，收报24902.53点。 中铝国际AH溢价达121.15%，位居AH股溢价率第18位。当日收盘，中铝国际A股报4.84元，涨幅 0.62%，H股报2.39港元，上涨1.27%。 资料显示，中铝国际工程股份有限公司(简称"中铝国际")成立于2003年12月16日,隶属于中国铝业集团有 限公司(以下简称"中铝集团")的工程技术经营单元,是中铝集团控股子公司,所在地位于北京市海淀区杏 石口路99号C座,拥有工程设计综合甲级资质,是中国有色金属行业领先的技术、工程服务与设备供应 商。中铝国际于2012年7月6日在香港联交所(H股代码:02068.HK)上市,于2018年8月31日在上海证券交易 所(A股代码:601068.SH)主板上市,成为"A+H"股有色工程技术第一股。 *注：AH股是指同时在A股和港股上市的公司，溢价（A/H）越大，说明H股相比A股越便宜。 本文源自：金融界 ...

Investment Rating - The industry investment rating is "Positive" and is maintained [8] Core Insights - The report highlights that the AH premium rates for A/H listed pharmaceutical companies remain at a high level, with significant premiums observed for various innovative drug companies and CXO firms as of August 1, 2025 [2][6] - The report indicates a trend of narrowing AH premium rates, suggesting that leading companies like Heng Rui Medicine and WuXi AppTec have begun to achieve valuation recovery, with Heng Rui's H shares experiencing a reversal in AH premium [7][28] - The report anticipates that as Chinese innovative pharmaceutical companies continue to advance their R&D pipelines and internationalization efforts, the Hong Kong stock market may enter a value reassessment phase, revealing structural investment opportunities [2][28] Summary by Sections AH Premium Rates - As of August 1, 2025, the AH premium rates for several innovative drug companies are as follows: BeiGene at 47.56%, Junshi Biosciences at 70.30%, Innovent Biologics at 83.37%, Fudan-Zhangjiang at 185.15%, and Rongchang Biologics at 17.36% [6][17] - For CXO companies, the AH premium rates are: Zhaoyan New Drug at 52.67%, Tigermed at 36.50%, Kanglong Chemical at 51.60%, and Kelaiying at 20.21% [6][17] Trends in AH Premium Rates - The report notes a significant decrease in AH premium rates since early 2025, with leading companies like Heng Rui Medicine and WuXi AppTec achieving notable valuation adjustments [7][23] - The AH premium rates for these companies have shown a marked decline from earlier levels, indicating a shift in market dynamics [23][28] Investment Perspectives - The report emphasizes that the ongoing "tenglong huan niao" (transformation) in medical insurance will continue to unfold, with innovative drugs being a primary investment focus [30] - It suggests that companies with healthy cash flows, strong innovation capabilities, and established R&D platforms are well-positioned for growth [30] - The report also highlights the importance of breakthrough therapies and technological advancements, particularly in areas such as cytokine immunotherapy and PD1-based therapies [30]

8月4日，上证指数涨0.66%，收报3583.31点，恒生指数涨0.92%，收报24733.45点。 中船防务AH溢价达91.53%，位居AH股溢价率第37位。当日收盘，中船防务A股报28.19元，涨幅 3.3%，H股报16.1港元，上涨7.33%。 本文源自：金融界 资料显示，中船海洋与防务装备股份有限公司是中国船舶集团有限公司属下的大型造船骨干企业之一, 其前身是广州广船国际股份有限公司。公司于1993年在上海和香港上市,是中国第一家A+H股上市造船 企业。 为推动行业兼并整合,实现战略性产能布局,增强综合竞争力,2014年、2015年,中船防务先后收购 了中船龙穴造船有限公司、中船黄埔文冲船舶有限公司,完成了对中船集团在华南地区优质造船资产的 整合,成为集海洋防务装备、海洋运输装备、海洋开发装备和海洋科考装备四大海洋装备于一体的大型 综合性海洋与防务装备企业集团。 今天,中船防务已经描绘出了致力于"成为全球海洋与重型装备市场技 术领先、服务卓越的一流企业"的宏伟蓝图。 *注：AH股是指同时在A股和港股上市的公司，溢价（A/H）越大，说明H股相比A股越便宜。 作者：行情君 ...

Core Viewpoint - The article highlights the performance of Zhejiang Shibao Co., Ltd., which has a significant A/H share premium and is recognized as a leading enterprise in the automotive steering system industry in China [1][2]. Company Overview - Zhejiang Shibao Co., Ltd. was established in 1984 and focuses on the research, development, manufacturing, and sales of automotive steering system products [1]. - The company was recognized as a "leading enterprise in the automotive steering gear industry" by the China Association of Automobile Manufacturers in 2009 and has been a key participant in setting steering gear standards in China [1]. - It has been awarded the title of "one of the top 100 excellent automotive parts suppliers in the country" for several consecutive years [1]. Business Strategy - The company adheres to a business philosophy of "pragmatism and innovation," continuously introducing advanced technologies and production testing equipment [1]. - It gathers domestic and international experts, technical talents, and management elites to enhance its operational capabilities [1]. - The implementation of lean production management aims to provide high-quality products and excellent services to both domestic and international customers [1]. Market Position - Zhejiang Shibao aims to develop into an internationally recognized brand in automotive steering systems and to become a long-term trusted partner for many well-known automobile manufacturers globally [1].

Group 1 - The Shanghai Composite Index rose by 0.66% to close at 3583.31 points, while the Hang Seng Index increased by 0.92% to 24733.45 points [1] - The premium of Haiprui's A-shares over H-shares reached 131.61%, ranking 14th among AH shares in terms of premium rate [1] - Haiprui's A-shares closed at 13.17 yuan, down 0.6%, and H-shares closed at 6.22 Hong Kong dollars, remaining flat [1] Group 2 - Shenzhen Haiprui Pharmaceutical Group Co., Ltd. was established in 1998 and is a leading multinational pharmaceutical company with A+H dual financing platforms [1] - The company operates across the entire heparin industry chain, biopharmaceutical CDMO, and the investment, development, and commercialization of innovative drugs [1] - Haiprui's three business segments are synergistic and driven by unmet clinical needs, aiming to provide high-quality, safe, and effective drugs and services to global patients [1]

8月4日，上证指数涨0.66%，收报3583.31点，恒生指数涨0.92%，收报24733.45点。 长城汽车AH溢价达81.93%，位居AH股溢价率第44位。当日收盘，长城汽车A股报22.22元，涨幅 2.4%，H股报13.36港元，上涨5.03%。 本文源自：金融界 作者：行情君 *注：AH股是指同时在A股和港股上市的公司，溢价（A/H）越大，说明H股相比A股越便宜。 资料显示，长城汽车股份有限公司是一家全球化智能科技公司,业务包括汽车及零部件设计、研发、生 产、销售和服务,旗下拥有哈弗、魏牌、欧拉、坦克及长城皮卡。长城汽车打造了以能源、智能化为导 向的森林生态体系,确立混动、纯电、氢能三轨并行发展,在智能驾驶、智能座舱、智慧底盘等方面进行 全产业链布局,构建了业内领先的"光伏+分布式储能+集中式储能"的能源体系,完成了"太阳能-电池-氢能- 车用动力"的全价值链布局。 ...

8月4日，上证指数涨0.66%，收报3583.31点，恒生指数涨0.92%，收报24733.45点。 本文源自：金融界 资料显示，万科企业股份有限公司成立于1984年,经过近四十年的发展,已成为国内领先的城乡建设与生 活服务商,公司业务聚焦全国经济最具活力的三大经济圈及中西部重点城市。自2016年首次跻身《财 富》"世界500强"以来,万科企业股份有限公司已连续9年上榜,2024年位列第206位。2014年,万科将公司 的"三好住宅供应商"的定位延展为"城市配套服务商"。在2018年将这一定位进一步迭代升级为"城乡建 设与生活服务商",并具体细化为四个角色:美好生活场景师,实体经济生力军,创新探索试验田,和谐生态建 设者。在不断发展的过程中,万科始终聚焦好产品好服务,如今正在向着"城乡建设与生活服务商"的目标 迈进。 作者：行情君 *注：AH股是指同时在A股和港股上市的公司，溢价（A/H）越大，说明H股相比A股越便宜。 万科ＡAH溢价达42.8%，位居AH股溢价率第91位。当日收盘，万科ＡA股报6.41元，涨幅0.31%，H股 报4.91港元，上涨0.2%。 ...

8月4日，上证指数涨0.66%，收报3583.31点，恒生指数涨0.92%，收报24733.45点。 中远海发AH溢价达133.86%，位居AH股溢价率第13位。当日收盘，中远海发A股报2.48元，涨幅 0.4%，H股报1.16港元，下跌0.85%。 资料显示，中远海运发展股份有限公司(「公司」)是中国远洋海运集团有限公司(「中远海运集团」)所 属专门从事航运物流产融运营的公司,是中远海运集团旗下核心产业之一。公司成立于1997年,总部设在 上海,是一家在香港、上海两地上市的公司。公司致力于围绕航运物流产业主线,以集装箱制造、集装箱 租赁及航运租赁业务为核心,以投资管理为支撑,实现产融投一体化发展。公司集装箱制造业务从事国际 标准干货箱、冷藏箱及特种箱的研究开发和生产销售,设计年产能超过140万TEU,位居世界第二,客户涵 盖全球知名班轮公司和各大租箱公司。公司深化集装箱租造协同,以科技创新、绿色低碳转型为抓手提 升核心竞争力,打造世界一流物流装备科技企业。 *注：AH股是指同时在A股和港股上市的公司，溢价（A/H）越大，说明H股相比A股越便宜。 本文源自：金融界 作者：行情君 ...